Schedule 13G ownership disclosure

Sarepta Therapeutics Inc

Security class unavailable · CUSIP: 803607100

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,364,627
Percent of class
6.1600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-22-004974
Form type
SC 13G
Filer
SANDS CAPITAL MANAGEMENT, LLC
CIK
CIK 1020066
Filed
Feb 14, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub